Publicaciones en las que colabora con MARÍA TERESA CABRERA CASTILLO (63)

2016

  1. Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

    Cancer Immunology, Immunotherapy, Vol. 65, Núm. 1, pp. 47-59

2014

  1. HIGH FREQUENCY OF HLA-DR EXPRESSION AND LEUKOCYTE INFILTRATION IN COLORECTAL CANCERS WITH MICROSATELLITE INSTABILITY

    TISSUE ANTIGENS

2013

  1. MHC class i antigens and the tumor microenvironment

    The Tumor Immunoenvironment (Springer Netherlands), pp. 253-286

2011

  1. Analysis of HLA-ABC gene expression in normal tissues by locus-specific quantitative real time PCR

    TISSUE ANTIGENS

  2. Galectin-3 and programmed cell death-1 ligand expression in colorectal microsatellite instability positive and negative tumors

    TISSUE ANTIGENS

  3. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 6, pp. 869-882

  4. Three different mechanisms underlying major histocompatibility complex class I down-regulation in colorectal carcinomas

    TISSUE ANTIGENS

2010

  1. Analysis of HLA-ABC locus-specific transcription in normal tissues

    Immunogenetics, Vol. 62, Núm. 11-12, pp. 711-719

  2. Different patterns of tumor infiltrating leukocytes in colorectal microsatellite instability positive and negative tumors

    TISSUE ANTIGENS

  3. Higher HLA class i expression in renal cell carcinoma than in autologous normal tissue

    Tissue Antigens, Vol. 75, Núm. 2, pp. 110-118

  4. Microsatellite instability colorectal carcinomas dysplay distinct gene expression profiles compatible with more immunogenic tumors

    TISSUE ANTIGENS

2009

  1. HLA and melanoma: Multiple alterations in HLA class i and II expression in human melanoma cell lines from ESTDAB cell bank

    Cancer Immunology, Immunotherapy, Vol. 58, Núm. 9, pp. 1507-1515

  2. HLA class I is up-regulated in malignantly transformed cells of renal tubules

    TISSUE ANTIGENS

2008

  1. Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

    Immunogenetics, Vol. 60, Núm. 8, pp. 439-447

  2. HLA class I expression in metastatic melanoma lesions determines the progression/regression of the metastases in response to immunotherapy

    TISSUE ANTIGENS

  3. HLA class I expression, tumor escape and cancer progression

    Current Cancer Therapy Reviews, Vol. 4, Núm. 2, pp. 105-110

  4. Transcriptional and posttranscriptional mechanisms can reduce blocks HLA-B surface expression in melanoma cells

    TISSUE ANTIGENS

2007

  1. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours

    Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226

  2. HLA class I antigen expression and tumor immune escape

    13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY

  3. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination

    Cancer Immunology, Immunotherapy, Vol. 56, Núm. 5, pp. 709-717